Teladoc Health, Inc. reported Second Quarter 2025 financial results with revenue at $631.9 million, down 2% from the previous year. Net loss was $32.7 million, adjusted EBITDA at $69.3 million. Integrated Care segment revenue increased by 4%, while BetterHelp segment revenue decreased by 9%. The company also paid $550.6 million to retire senior notes and secured a $300 million credit facility.

Teladoc Health’s CEO, Chuck Divita, expressed satisfaction with second-quarter performance, emphasizing virtual care as a performance multiplier in healthcare. Revenue decreased by 2% to $631.9 million, with U.S. revenue down 4% and International revenue up 10%. Net loss for the quarter was $32.7 million, adjusted EBITDA decreased by 23% to $69.3 million.

For the first six months of 2025, Teladoc Health reported a 2% decrease in revenue to $1.26 billion, with a net loss of $125.7 million. Adjusted EBITDA decreased by 17% to $127.4 million. The company highlighted a non-cash goodwill impairment charge of $59.1 million and a tax benefit related to acquisitions in the financial results.

Teladoc Health’s financial outlook for 2025 includes revenue expectations of $2.5-$2.548 billion, adjusted EBITDA of $263-$294 million, and a net loss per share of ($1.00)-($1.35). The company anticipates free cash flow of $170-$200 million and projects U.S. Integrated Care members to reach 101-103 million.

The company also provided an outlook for the third quarter of 2025, forecasting revenue of $614-$636 million, adjusted EBITDA of $56-$70 million, and a net loss per share of ($0.20)-($0.35). U.S. Integrated Care members are expected to reach 101.5-102.5 million. Teladoc Health aims to maintain a strong balance sheet, invest in business growth, and evaluate share repurchases as potential uses of excess cash.

Teladoc Health uses non-GAAP financial measures like adjusted EBITDA and free cash flow to enhance understanding of past performance. Adjusted EBITDA consists of net loss adjustments, while free cash flow is calculated as net cash provided by operating activities minus capital expenditures. The company believes these measures provide insight into operating performance and liquidity.

Read more at GlobeNewswire.: Teladoc Health Reports Second Quarter 2025 Results